Skip to main content
. 2013 May 13;2013:726925. doi: 10.1155/2013/726925

Table 2.

Predicted duration of survival versus actual duration of survival (by DS-GPA score).

Patient DS-GPA Predicted median duration of survival based on DS-GPA (months) Duration of survival from HD IL-2 initiation (months) Duration of survival from diagnosis of brain metastases (months)
8 1 3.38 3.0 4.7

1 2 4.7 6.7 7.4
4 2 4.7 13.3 15.2
5 2 4.7 18.2 19.6
6 2 4.7 5.3 5.4

2 3 8.77 10.6 13.5
7 3 8.77 2.1 5.1

3 4 13.2 19.0 23.7